Stichting Tuberculosis Vaccine Initiative

Analysis

Stichting Tuberculosis Vaccine Initiative is a registered charity in United States, based in Netherlands. It received its IRS tax-exemption ruling in November 2009, 17 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3).

In the financial year ending December 2023, Stichting Tuberculosis Vaccine Initiative reported income of $792k and spending of $820k, spending 104% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $1.6m to $792k (-50%), an average of -16% a year. The sharpest change came in the year to December 2022, when income dropped by 40%. Over the whole period it spent 103% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Stichting Tuberculosis Vaccine Initiative sits at the 61st percentile: it is larger than about 61% of them. Against every charity in United States with reported income it ranks in the 76th percentile. Charities of a similar size with the same main cause include Simons Fund ($792k), Health for All Clinic Inc ($792k) and Lions Vision Services a South Carolina Charity ($792k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 97% of the total. Compensation of current officers, directors and key employees was $383k (47% of expenses). At year end it held assets of $2.2m against liabilities of $2.1m, net assets of $43k.